APA (7th ed.) Citation

HH, G., M, L., SM, E., EEM, E., HM, A., HH, G., & MA, H. (2018). Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries. Dove Medical Press.

Chicago Style (17th ed.) Citation

HH, Ghoraba, Leila M, Elgouhary SM, Elgemai EEM, Abdelfattah HM, Ghoraba HH, and Heikal MA. Safety of High-dose Intravitreal Triamcinolone Acetonide as Low-cost Alternative to Anti-vascular Endothelial Growth Factor Agents in Lower-middle-income Countries. Dove Medical Press, 2018.

MLA (8th ed.) Citation

HH, Ghoraba, et al. Safety of High-dose Intravitreal Triamcinolone Acetonide as Low-cost Alternative to Anti-vascular Endothelial Growth Factor Agents in Lower-middle-income Countries. Dove Medical Press, 2018.